Moringa Acquisition Corp
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MACA research report →
Price Chart
About the company
At present, Moringa Acquisition Corp lacks substantial commercial operations. The company's core objective is to execute a strategic business combination, such as a merger, asset acquisition, share purchase, or reorganization, with one or more entities. Its search is specifically directed towards technology-focused enterprises or sectors within Israel.
- CEO
- Ilan Levin
- IPO
- 2021
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on MACA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $36.61M
- P/E
- 129.95
- PEG
- -1.09
- P/S
- 0.00
- P/B
- 11.99
- EV/EBITDA
- -35.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.44%
- ROIC
- -19.70%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,122,480
- Net Income
- $263.07K-89.6%
- EPS
- $0.07-57.2%
- OCF Growth
- -62.5%
- FCF Growth
- -62.5%
- 52W High
- $13.56
- 52W Low
- $8.64
- 50D MA
- $11.68
- 200D MA
- $11.23
- Beta
- 0.02
- RSI (14)
- 33
- Avg Volume
- 4.75K
No earnings-call transcripts are available for MACA yet.
- Free Float
- 19.9%
- Shares Outstanding
- 3.87M
- Float Shares
- 770.02K
of shares held by institutions
7 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 1 ETFs
Biggest fund positions in MACA by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 22, 23 | Hudson Bay Capital Management LP | other | 401,271 |
| Feb 9, 23 | Hudson Bay Capital Management LP | other | 0 |
| Feb 16, 21 | Yalon Dan | other | 0 |
| Mar 3, 21 | Moringa Sponsor, LP | buy | 27,857 |
| Feb 19, 21 | Moringa Sponsor, LP | buy | 325,000 |
| Feb 16, 21 | Moringa Sponsor, LP | other | 0 |
| Feb 16, 21 | Maman Gil | other | 0 |
| Feb 16, 21 | Levin Ilan | other | 0 |
| Feb 16, 21 | Alon Ruth | other | 0 |
| Feb 16, 21 | Brachfeld Eric | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MACA coverage
Recent articles, reports, and earnings notes.
No research on MACA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MACA report →Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
globenewswire.com · Feb 22
MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION
globenewswire.com · Aug 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.